Literature DB >> 30023005

Intestinal ultrasound in assessment of suspected Crohn's disease in patients with negative ileocolonoscopy: a paradigm shift?

Taiwo A Ajose1, Titilope Olanipekun2, Valery S Effoe2, Nicolas Bakinde2.   

Abstract

Entities:  

Year:  2018        PMID: 30023005      PMCID: PMC6047238          DOI: 10.1177/1756284818787397

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


× No keyword cloud information.
Dear Editor, We read with great interest the article ‘The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileocolonoscopy’ by Carter and colleagues published in a recent issue of Therapeutic Advances in Gastroenterology. This is a noteworthy study given the rise in incidence and growing public-health concerns of Crohn’s disease (CD), which has led to much research, especially in the area of diagnosis.[1] CD is a very debilitating illness that can severely affect the quality of life and productivity of affected individuals. Therefore, a timely diagnosis, which could lead to earlier management, improved quality of life, and workplace productivity is of high importance. In North America, computed tomography (CT) enterography and magnetic resonance enterography (MRE) are two imaging modalities increasingly being used in the diagnosis of small bowel CD, especially in patients with normal ileocolonoscopy.[2] Though CT enterography has a better image quality and minimal intra-observer variability compared with MRE, they both have similar diagnostic accuracy (sensitivity of about 95%), and the ability to simultaneously assess mural and extramural CD manifestations.[3] However, the use of CT enterography and MRE for the diagnosis of small bowel CD is limited by cost and availability. In addition, CT enterography is particularly associated with exposure to ionizing radiation. The relapsing nature of CD often leads to patients undergoing multiple abdominal CT imaging in their lifetime, increasing cumulative exposure to radiation. Thus, the use of intestinal ultrasound (IUS), as described in the paper by Carter and colleagues, is very appealing given its low cost and decreased exposure to ionizing radiation. Abdominal ultrasound is widely used in clinical practice, both in resource-rich and resource-limited settings. The relapsing potential of CD makes IUS a potentially good imaging alternative to abdominal CT. Some studies have reported IUS to have similar diagnostic accuracies to CT enterography and MRE,[4] further giving credence to the fact that IUS may be a useful diagnostic tool in suspected cases of CD where ileocolonoscopy is negative as suggested by the authors. A limitation of the current paper may be the non-use of oral contrast in their imaging technique. One study reported improved diagnostic accuracy of IUS with the addition of oral contrast compared with standard IUS.[5] A reasonable next step in this area of research would be to compare the diagnostic accuracies of standard IUS, oral contrast-enhanced IUS, CT enterography, and MRE in the diagnosis of CD affecting the small bowel and Crohn’s flares. Contrast-enhanced IUS may prove comparable to CT enterography and MRE in, not only diagnosis, but also in assessing the extent of disease, thus arguing in favor of its use in clinical practice.
  5 in total

1.  Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopy.

Authors:  Sunil Samuel; David H Bruining; Edward V Loftus; Brenda Becker; Joel G Fletcher; Jayawant N Mandrekar; Alan R Zinsmeister; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2012-04-10       Impact factor: 11.382

2.  Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies.

Authors:  Karin Horsthuis; Shandra Bipat; Roelof J Bennink; Jaap Stoker
Journal:  Radiology       Date:  2008-04       Impact factor: 11.105

Review 3.  Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.

Authors:  Siew C Ng; Hai Yun Shi; Nima Hamidi; Fox E Underwood; Whitney Tang; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Justin C Y Wu; Francis K L Chan; Joseph J Y Sung; Gilaad G Kaplan
Journal:  Lancet       Date:  2017-10-16       Impact factor: 79.321

4.  Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease.

Authors:  Hassan A Siddiki; Jeff L Fidler; Joel G Fletcher; Sharon S Burton; James E Huprich; David M Hough; C Daniel Johnson; David H Bruining; Edward V Loftus; William J Sandborn; Darrell S Pardi; Jayawant N Mandrekar
Journal:  AJR Am J Roentgenol       Date:  2009-07       Impact factor: 3.959

Review 5.  Advanced imaging techniques for small bowel Crohn's disease: what does the future hold?

Authors:  Inês Pita; Fernando Magro
Journal:  Therap Adv Gastroenterol       Date:  2018-02-12       Impact factor: 4.409

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.